Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription Articles published in Acta Psychiatr Scand Retrieve available abstracts of 65 articles: HTML format

Single Articles

December 2024
1. FORTE MF, Clougher D, Segura AG, Mezquida G, et al
   From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis.
   Acta Psychiatr Scand. 2024 Dec 25. doi: 10.1111/acps.13779.
   PubMed     Abstract available
   
   
   November 2024
2. ODSBU I, Hamina A, Hjellvik V, Handal M, et al
   Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study.
   Acta Psychiatr Scand. 2024 Nov 29. doi: 10.1111/acps.13776.
   PubMed     Abstract available
   
   
   
3. TAHMAZOV E, Bosse J, Glemain B, Nabbe P, et al
   Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis.
   Acta Psychiatr Scand. 2024 Nov 27. doi: 10.1111/acps.13773.
   PubMed     Abstract available
   
   
   
4. D'ANDREA G, Quattrone D, Tripoli G, Spinazzola E, et al
   Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study.
   Acta Psychiatr Scand. 2024 Nov 1. doi: 10.1111/acps.13767.
   PubMed     Abstract available
   
   
   October 2024
5. MADSEN NM, Sorensen MA, Danielsen AA, Hojlund M, et al
   The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two-cohort study among patients with first-episode schizophrenia.
   Acta Psychiatr Scand. 2024 Oct 8. doi: 10.1111/acps.13760.
   PubMed     Abstract available
   
   
   September 2024
6. VAN OPSTAL DPJ, Kia SM, Jakob L, Somers M, et al
   Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.
   Acta Psychiatr Scand. 2024 Sep 18. doi: 10.1111/acps.13754.
   PubMed     Abstract available
   
   
   
7. COHN AB, Yang YS
   The effects of individualism versus collectivism on clozapine policy stringency.
   Acta Psychiatr Scand. 2024;150:180-181.
   PubMed    
   
   
   August 2024
8. KEINANEN J, Eskelinen S, From T, Laurikainen H, et al
   Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.
   Acta Psychiatr Scand. 2024 Aug 29. doi: 10.1111/acps.13752.
   PubMed     Abstract available
   
   
   
9. LIN YP, Chen WY, Pan CH, Su SS, et al
   Age-stratified risk of suicide in patients with schizophrenia.
   Acta Psychiatr Scand. 2024 Aug 14. doi: 10.1111/acps.13747.
   PubMed     Abstract available
   
   
   
10. AMBROSEN KS, Lemvigh CK, Nielsen MO, Glenthoj BY, et al
    Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naive patients with first-episode psychosis.
    Acta Psychiatr Scand. 2024 Aug 12. doi: 10.1111/acps.13743.
    PubMed     Abstract available
    
    
    July 2024
11. SASS MR, Christensen AMB, Christensen ML, Gruber E, et al
    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.
    Acta Psychiatr Scand. 2024;150:35-47.
    PubMed     Abstract available
    
    
    June 2024
12. BERKHOF M, van der Stouwe ECD, Pot-Kolder RMCA, van der Gaag M, et al
    Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
    Acta Psychiatr Scand. 2024 Jun 9. doi: 10.1111/acps.13713.
    PubMed     Abstract available
    
    
    April 2024
13. CLARK I, Wallman P, Gee S, Taylor D, et al
    Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study.
    Acta Psychiatr Scand. 2024 Apr 15. doi: 10.1111/acps.13691.
    PubMed    
    
    
    
14. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    PubMed     Abstract available
    
    
    February 2024
15. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
    Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
    Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
    PubMed     Abstract available
    
    
    
16. TSUKAHARA M, So R, Yoshimura Y, Nakajima S, et al
    Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year r
    Acta Psychiatr Scand. 2024 Feb 15. doi: 10.1111/acps.13674.
    PubMed    
    
    
    January 2024
17. ARAUJO MB, Nogueira GN, Silveira PLSD, de Souza Junior SA, et al
    Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2024 Jan 23. doi: 10.1111/acps.13659.
    PubMed    
    
    
    
18. DREVINSKAITE M, Kaceniene A, Patasius A, Stukas R, et al
    Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Acta Psychiatr Scand. 2024 Jan 3. doi: 10.1111/acps.13651.
    PubMed     Abstract available
    
    
    December 2023
19. EDVARDSEN E, Moszkowicz M, Olsen AL, Heinrichsen M, et al
    Clinical and sociodemographic features in offspring aged 0-3 years of mothers with schizophrenia spectrum disorders. A descriptive cross-sectional study.
    Acta Psychiatr Scand. 2023 Dec 10. doi: 10.1111/acps.13641.
    PubMed     Abstract available
    
    
    
20. OLOYEDE E, Dima A, Taylor D, Cheung H, et al
    Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Acta Psychiatr Scand. 2023;148:538-552.
    PubMed     Abstract available
    
    
    November 2023
21. JOHN AP, Mya T, Haywood D
    Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    Acta Psychiatr Scand. 2023 Nov 10. doi: 10.1111/acps.13627.
    PubMed     Abstract available
    
    
    September 2023
22. TSUKAHARA M, So R, Yoshimura Y, Yamashita R, et al
    Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Acta Psychiatr Scand. 2023 Sep 8. doi: 10.1111/acps.13612.
    PubMed     Abstract available
    
    
    August 2023
23. CHENG CS, Chen WY, Chang HM, Pan CH, et al
    Unfavorable cancer mortality-to-incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000-2019.
    Acta Psychiatr Scand. 2023 Aug 21. doi: 10.1111/acps.13604.
    PubMed     Abstract available
    
    
    
24. VOCHOSKOVA K, McWhinney SR, Fialova M, Kolenic M, et al
    Weight and metabolic changes in early psychosis-association with daily quantification of medication exposure during the first hospitalization.
    Acta Psychiatr Scand. 2023 Aug 1. doi: 10.1111/acps.13594.
    PubMed     Abstract available
    
    
    May 2023
25. KOHLER-FORSBERG O, Antonsen S, Pedersen CB, Mortensen PB, et al
    Schizophrenia spectrum disorders in Denmark between 2000 and 2018: Incidence and early diagnostic transition.
    Acta Psychiatr Scand. 2023 May 26. doi: 10.1111/acps.13565.
    PubMed     Abstract available
    
    
    April 2023
26. ALLEBECK P, Gunnarsson T, Lundin A, Lofving S, et al
    Does a history of cannabis use influence onset and course of schizophrenia?
    Acta Psychiatr Scand. 2023 Apr 24. doi: 10.1111/acps.13562.
    PubMed     Abstract available
    
    
    March 2023
27. VALLI I, Segura AG, Verdolini N, Garcia-Rizo C, et al
    Obstetric complications and genetic risk for schizophrenia: differential role of antenatal and perinatal events in first episode psychosis.
    Acta Psychiatr Scand. 2023 Mar 13. doi: 10.1111/acps.13546.
    PubMed     Abstract available
    
    
    
28. WILLIAMS TF, Walker EF, Strauss GP, Woods SW, et al
    The reliability and validity of the Revised Green et al. Paranoid Thoughts Scale in individuals at clinical high-risk for psychosis.
    Acta Psychiatr Scand. 2023 Mar 11. doi: 10.1111/acps.13545.
    PubMed     Abstract available
    
    
    December 2022
29. LI Z, Wang Y, Wang Z, Kong L, et al
    Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Acta Psychiatr Scand. 2022 Dec 30. doi: 10.1111/acps.13530.
    PubMed     Abstract available
    
    
    September 2022
30. SANCHEZ-GUTIERREZ T, Barbeito S, Gomez-Juncal R, Rodriguez-Ortega E, et al
    Neuropsychological Functioning and Suicidal Behaviours in Patients with First-Episode Psychosis: A Systematic Review.
    Acta Psychiatr Scand. 2022 Sep 25. doi: 10.1111/acps.13501.
    PubMed     Abstract available
    
    
    
31. PURANEN A, Koponen M, Lahteenvuo M, Tanskanen A, et al
    Real-world effectiveness of mood stabilizer use in schizophrenia.
    Acta Psychiatr Scand. 2022 Sep 5. doi: 10.1111/acps.13498.
    PubMed     Abstract available
    
    
    
32. STOGIOS N, Maksyutynska K, Navagnanavel J, Sanches M, et al
    Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study.
    Acta Psychiatr Scand. 2022;146:190-200.
    PubMed     Abstract available
    
    
    July 2022
33. GYLLENBERG D, Ristikari T, Kelleher I, Kaariala A, et al
    School Performance and Later Diagnoses of Non-Affective Psychoses, Bipolar Disorder and Depression.
    Acta Psychiatr Scand. 2022 Jul 25. doi: 10.1111/acps.13481.
    PubMed     Abstract available
    
    
    
34. BENROS ME
    High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis.
    Acta Psychiatr Scand. 2022;146:3-5.
    PubMed    
    
    
    May 2022
35. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    PubMed     Abstract available
    
    
    April 2022
36. BAANDRUP L, Allerup P, Nielsen MO, During SW, et al
    Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Acta Psychiatr Scand. 2022 Apr 13. doi: 10.1111/acps.13434.
    PubMed     Abstract available
    
    
    March 2022
37. SPILKA MJ, Keller WR, Buchanan RW, Gold JM, et al
    Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
    Acta Psychiatr Scand. 2022 Mar 4. doi: 10.1111/acps.13421.
    PubMed     Abstract available
    
    
    February 2022
38. DUNLEAVY C, Elsworthy RJ, Upthegrove R, Wood SJ, et al
    Inflammation in First-Episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2022 Feb 24. doi: 10.1111/acps.13416.
    PubMed     Abstract available
    
    
    
39. MORENO-KUSTNER B, Fabrega-Ruz J, Gonzalez-Caballero JL, Reyes S, et al
    The Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS): Development and Validation.
    Acta Psychiatr Scand. 2022 Feb 21. doi: 10.1111/acps.13417.
    PubMed     Abstract available
    
    
    
40. VERDOLINI N, Borras R, Sparacino G, Garriga M, et al
    The prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.
    Acta Psychiatr Scand. 2022 Feb 16. doi: 10.1111/acps.13415.
    PubMed     Abstract available
    
    
    
41. BRODEUR S, Vanasse A, Courteau J, Stip E, et al
    Comparative Effectiveness and Safety of Antipsychotic Drugs in Patients with Schizophrenia Initiating or Reinitiating Treatment: A Real-World Observational Study.
    Acta Psychiatr Scand. 2022 Feb 14. doi: 10.1111/acps.13413.
    PubMed     Abstract available
    
    
    
42. TESLI M, Degerud E, Plana-Ripoll O, Gustavson K, et al
    Educational attainment and mortality in schizophrenia.
    Acta Psychiatr Scand. 2022 Feb 13. doi: 10.1111/acps.13407.
    PubMed     Abstract available
    
    
    
43. BRODEUR S, Vanasse A, Courteau J, Courteau M, et al
    Antipsychotic Utilization Trajectories Three Years After Initiating or Reinitiating Treatment of Schizophrenia: A State Sequence Analysis Approach.
    Acta Psychiatr Scand. 2022 Feb 12. doi: 10.1111/acps.13411.
    PubMed     Abstract available
    
    
    January 2022
44. MURILLO-GARCIA N, Diaz-Pons A, Fernandez-Cacho LM, Miguel-Cossrredera M, et al
    A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype.
    Acta Psychiatr Scand. 2022 Jan 25. doi: 10.1111/acps.13404.
    PubMed     Abstract available
    
    
    
45. BALLESTER PL, Romano MT, de Azevedo Cardoso T, Hassel S, et al
    Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2022;145:42-55.
    PubMed     Abstract available
    
    
    December 2021
46. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    PubMed     Abstract available
    
    
    November 2021
47. NIELSEN J
    Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.
    Acta Psychiatr Scand. 2021;144:419-421.
    PubMed    
    
    
    
48. SISKIND D, Sharma M, Pawar M, Pearson E, et al
    Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.
    Acta Psychiatr Scand. 2021;144:422-432.
    PubMed     Abstract available
    
    
    October 2021
49. MUSTAFA SS, Malla A, Joober R, Abadi S, et al
    Unfinished business: Functional outcomes in a randomized controlled trial of a three-year extension of early intervention versus regular care following two years of early intervention for psychosis.
    Acta Psychiatr Scand. 2021 Oct 2. doi: 10.1111/acps.13377.
    PubMed     Abstract available
    
    
    September 2021
50. PARK CI, Han M, Jung I, Kim EH, et al
    A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Acta Psychiatr Scand. 2021 Sep 26. doi: 10.1111/acps.13375.
    PubMed     Abstract available
    
    
    August 2021
51. SMITH E, Singh R, Lee J, Colucci L, et al
    Adiposity in Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Aug 30. doi: 10.1111/acps.13365.
    PubMed     Abstract available
    
    
    
52. KRISTENSEN TD, Glenthoj LB, Ambrosen K, Syeda W, et al
    Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Acta Psychiatr Scand. 2021 Aug 1. doi: 10.1111/acps.13355.
    PubMed     Abstract available
    
    
    
53. HSU CW, Tseng PT, Tu YK, Lin PY, et al
    Month of birth and mental disorders: A population-based study and validation using global meta-analysis.
    Acta Psychiatr Scand. 2021;144:153-167.
    PubMed     Abstract available
    
    
    July 2021
54. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    PubMed     Abstract available
    
    
    
55. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    PubMed     Abstract available
    
    
    
56. BARCELLA CA, Polcwiartek C, Mohr GH, Hodges G, et al
    Severe mental illness is associated with increased mortality and severe course of COVID-19.
    Acta Psychiatr Scand. 2021;144:82-91.
    PubMed     Abstract available
    
    
    June 2021
57. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    PubMed    
    
    
    May 2021
58. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    PubMed     Abstract available
    
    
    April 2021
59. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    PubMed     Abstract available
    
    
    
60. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    PubMed     Abstract available
    
    
    
61. WHISKEY E, Barnard A, Oloyede E, Dzahini O, et al
    An evaluation of the variation and underuse of clozapine in the United Kingdom.
    Acta Psychiatr Scand. 2021;143:339-347.
    PubMed     Abstract available
    
    
    March 2021
62. VAN DER ZALM Y, Foldager L, Termorshuizen F, Sommer IE, et al
    Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    Acta Psychiatr Scand. 2021;143:216-226.
    PubMed     Abstract available
    
    
    
63. YADA Y, Kitagawa K, Sakamoto S, Ozawa A, et al
    The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study.
    Acta Psychiatr Scand. 2021;143:227-237.
    PubMed     Abstract available
    
    
    March 2020
64. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    PubMed     Abstract available
    
    
    
65. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.